Cargando…
Exosomal delivery of TRAIL and miR-335 for the treatment of hepatocellular carcinoma (Review)
Liver cancer is the sixth most prevalent type of cancer worldwide and accounts for the third most frequent cause of cancer-associated mortality. Conventional anticancer drugs display limited efficacy owing to their short half-life, poor solubility and inefficient drug delivery. Despite advancements...
Autores principales: | Thapa, Nikita, Chwae, Yong Joon, Yoo, Kwang Ho, Won, Tae-Bin, Kang, Daewook, Choi, Daae, Kim, Jaeyoung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9728509/ https://www.ncbi.nlm.nih.gov/pubmed/36416311 http://dx.doi.org/10.3892/ijmm.2022.5206 |
Ejemplares similares
-
Possibility of exosome-based coronavirus disease 2019 vaccine
por: Yoo, Kwang Ho, et al.
Publicado: (2022) -
Transforming growth factor-β family and stem cell-derived exosome therapeutic treatment in osteoarthritis (Review)
por: Yoo, Kwang Ho, et al.
Publicado: (2022) -
Characterization of miR-335-5p and miR-335-3p in human osteoarthritic tissues
por: Wilson, Thomas G., et al.
Publicado: (2023) -
Functions and Targets of miR-335 in Cancer
por: Ye, Lingling, et al.
Publicado: (2021) -
Epigenetic silencing of miR-335 and its host gene MEST in hepatocellular carcinoma
por: DOHI, OSAMU, et al.
Publicado: (2012)